Novo Nordisk Ignored Internal Warnings On Wegovy Launch Preparedness: Report
Novo Nordisk executives overlooked warnings ahead of Wegovy’s launch, leading to supply issues, high costs, and challenges competing with Eli Lilly’s Zepbound. read more
Read More
What’s Going On With Rocket Lab Stock On Tuesday?
Rocket Lab shares rise after clearing a key design milestone for its U.S. defense satellite mission. read more
